文献速递肝病

肝病(包括非酒精性脂肪性肝病)的营养几何学

The nutritional geometry of liver disease including non-alcoholic fatty liver disease.
PubMed 文献 · J Hepatol · 2017-11-06

综述提出营养几何框架(GFN)作为设计营养实验和解读营养数据的新模型,可分析营养素及其交互作用对动物行为和表型的影响;小鼠研究已用GFN区分宏量营养素对脂肪肝和肠道微生物组的作用,GFN可能有助于解析营养素对人类肝病尤其是非酒精性脂肪性肝病的影响。

要点

  • 营养对慢性肝病尤其是非酒精性脂肪性肝病有深远影响。
  • 既往研究多关注总能量或单一营养素如维生素D对肝病的影响。
  • 营养几何框架(GFN)可解析营养素及其交互作用对肝病的影响。

核心结论

  • 营养几何框架(GFN)可能对解析营养素对人类肝病尤其是非酒精性脂肪性肝病的影响发挥重要作用。

研究设计与样本

  • 综述,检索范围原文未报告。

主要发现

  • 大多数观察性研究和临床试验关注总能量摄入或单个宏量营养素及某些微量营养素(如维生素D)对肝病的影响。
  • 这些研究显示了营养对肝脏结局的重要性,但尚无统一框架理解饮食与肝病之间的关系。
  • 营养几何框架(GFN)是设计营养实验或解读营养数据的创新模型,可确定营养素及其交互作用对动物行为和表型的影响。
  • GFN已为理解膳食能量和宏量营养素对哺乳动物(包括人类)肥胖和衰老的关系提供见解。
  • 使用GFN的小鼠研究已区分宏量营养素对脂肪肝和肠道微生物组的作用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Nutrition has a profound effect on chronic liver disease, especially non-alcoholic fatty liver disease (NAFLD). Most observational studies and clinical trials have focussed on the effects of total energy intake, or the intake of individual macronutrients and certain micronutrients, such as vitamin D, on liver disease. Although these studies have shown the importance of nutrition on hepatic outcomes, there is not yet any unifying framework for understanding the relationship between diet and liver disease. The Geometric Framework for Nutrition (GFN) is an innovative model for designing nutritional experiments or interpreting nutritional data that can determine the effects of nutrients and their interactions on animal behaviour and phenotypes. Recently the GFN has provided insights into the relationship between dietary energy and macronutrients on obesity and ageing in mammals including humans. Mouse studies using the GFN have disentangled the effects of macronutrients on fatty liver and the gut microbiome. The GFN is likely to play a significant role in disentangling the effects of nutrients on liver disease, especially NAFLD, in humans.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Simpson SJ, Raubenheimer D, Cogger VC, et al. The nutritional geometry of liver disease including non-alcoholic fatty liver disease. J Hepatol. 2017. PMID: 29122389. doi:10.1016/j.jhep.2017.10.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。